ANTIBODY-DRUG CONJUGATES
Clinical trials for ANTIBODY-DRUG CONJUGATES explained in plain language.
Never miss a new study
Get alerted when new ANTIBODY-DRUG CONJUGATES trials appear
Sign up with your email to follow new studies for ANTIBODY-DRUG CONJUGATES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for hard-to-treat cancers: experimental drug targets HER2-positive tumors
Disease control Recruiting nowThis study tests a drug called trastuzumab rezetecan in people with advanced solid tumors that have stopped responding to standard therapies. The drug is given every three weeks to 90 participants divided into three groups based on their cancer type. Researchers will measure how …
Matched conditions: ANTIBODY-DRUG CONJUGATES
Phase: PHASE2 • Sponsor: Sheng Zhang • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Socks against side effects: simple stockings may shield nerves during chemo
Prevention Recruiting nowThis study tests whether wearing a compression stocking on one foot during antibody-drug conjugate (ADC) infusions can prevent peripheral neuropathy (nerve damage causing numbness or pain). Fifty-eight advanced cancer patients will wear a stocking on their left foot only, while t…
Matched conditions: ANTIBODY-DRUG CONJUGATES
Phase: NA • Sponsor: Sheng Zhang • Aim: Prevention
Last updated Jun 26, 2026 16:56 UTC